Volver al
artículo.
Referencias para el artículo
- Poikolainen K, Reunala T, Karvonen J, et al. Alcohol intake: a risk factor for
psoriasis in young and middle aged men? BMJ 1990;300:780–3.
- Monk BE, Neill SM. Alcohol consumption and psoriasis. Dermatologica
1986;173:57–60.
- Douglas JM. Psoriasis and diet. West J Med 1980;133:450
[letter].
- Michaelsson G, Gerden B. How common is gluten intolerance among patients with
psoriasis? Acta Derm Venereol 1991;71:90.
- Bazex A, Gaillet L, Bazex J. Gluten-free diet and psoriasis. Ann Dermatol
Syphiligr 1976;103:648–50 [in French].
- Michäelsson G, Gerdén B, Hagforsen E, et al. Psoriasis patients with
antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol
2000;142:44–51.
- Ameen M, Russell-Jones R. Fumaric acid esters: an alternative systemic
treatment for psoriasis. Clin Experiment Dermatol 1999;24:361–4.
- Mrowietz U, Christophers E, Altmeyer P. Treatment of severe psoriasis with
fumaric acid esters: scientific background and guidelines for therapeutic use. Br J
Dermatol 1999;141:424–9.
- Kolbach DN, Nieboer C. Fumaric acid therapy in psoriasis: results and side
effects of 2 years of treatment. J Am Acad Dermatol 1992;27:769–71.
- Altmeyer PJ, Matthes U, Pawlak F, et al. Antipsoriatic effect of fumaric acid
derivatives. J Am Acad Dermatol 1994;30:977–81.
- Nugteren-Huying WM, van der Schroeff JG, Hermans J, Suurmond D. Fumaric acid
therapy for psoriasis: a randomized, double-blind, placebo-controlled study. J Am Acad
Dermatol 1990;22:311–2.
- Nieboer C, de Hoop D, Langendijk PN, et al. Fumaric acid therapy in psoriasis:
a double-blind comparison between fumaric acid compound therapy and monotherapy with
dimethylfumaric acid ester. Dermatologica 1990;181:33–7.
- Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric
acid esters: results of a prospective multicentre study. German Multicentre Study. Br J
Dermatol 1998;138:456–60.
- Nieboer C, de Hoop D, van Loenen AC, et al. Systemic therapy with fumaric acid
derivates: new possibilities in the treatment of psoriasis. J Am Acad Dermatol
1989;20:601–8 [review].
- Bittiner SB, Tucker WFG, Cartwright I, Bleehen SS. A double-blind, randomised,
placebo-controlled trial of fish oil in psoriasis. Lancet 1988;i:378–80.
- Kojima T, Terano T, Tanabe E, et al. Long-term administration of highly
purified eicosapentaenoic acid provides improvement of psoriasis. Dermatologica
1991;182:225–30.
- Kojima T, Ternao T, Tanabe E, et al. Effect of highly purified
eicosapentaenoic acid on psoriasis. J Am Acad Dermatol 1989;21:150–1.
- Soyland E, Funk J, Rajka G, et al. Effect of dietary supplementation with
very-long-chain n-3 fatty acids in patients with psoriasis. N Engl J Med
1993;328:1812–6.
- Dewsbury CE, Graham P, Darley CR. Topical eicosapentaenoic acid (EPA) in the
treatment of psoriasis. Br J Dermatol 1989;120:581–4.
- Mayser P, Mrowietz U, Arenberger P, et al. W-3 Fatty acid-based lipid infusion
in patients with chronic plaque psoriasis: results of a double-blind, randomized,
placebo-controlled, multicenter trial. J Am Acad Dermatol 1998;38:539–47.
- Ashley JM, Lowe NJ, Borok ME, Alfin-Slater RB. Fish oil supplementation
results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or
acitretin therapy. J Am Acad Dermatol 1988;19:76–82.
- Oster KA. A cardiologist considers psoriasis Cutis
1977;20:39–40,45.
- Morimoto S, Yoshikawa K, Kozuka T, et al. An open study of vitamin D3
treatment in psoriasis vulgaris. Br J Dermatol 1986;115:421–9.
- Morimoto S, Yoshikawa K. Psoriasis and vitamin D3. Arch Dermatol
1989;125:231–4.
- Kragballe K. Treatment of psoriasis by the topical application of the novel
cholecalciferol analogue calcipotriol. Arch Dermatol 1989;125:1647–52.
- Smith EL, Pincus SH, Donovan L, Holick MF. A novel approach for the evaluation
and treatment of psoriasis. J Am Acad Dermatol 1988;19:516–28.
- Kragballe K, Beck HI, Sogaard H. Improvement of psoriasis by a topical vitamin
D3 analogue (MC 903) in a double-blind study. Br J Dermatol
1988;119:223–30.
- Henderson CA, Papworth-Smith J, Cunliffe WJ, et al. A double-blind,
placebo-controlled trial of topical 1,25-dihydroxycholecalciferol in psoriasis. Br J
Dermatol 1989;121:493–6.
- Van de Kerkhof PCM, Van Bokhoven M, Zultak M, Czarnetzki BM. A double-blind
study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis. Br J Dermatol
1989;120:661–4.
- Ellis CN, Berberian B, Sulica VI, et al. A double-blind evaluation of topical
capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993;29:438–42.
- Syed TA, Ahmed SA, Holt AH, et al. Management of psoriasis with Aloe
vera extract in a hydrophilic cream: A placebo-controlled, double-blind study.
Tropical Med Inter Health 1996;1:505–9.
- Hoffman D. The Herbal Handbook: A User’s Guide to Medical
Herbalism. Rochester, VT: Healing Arts Press, 1988, 23–4 [review].
- Bone K. Clinical Applications of Ayurvedic and Chinese Herbs.
Warwick, Queensland, Australia: Phytotherapy Press, 1996, 103–7.
- Wiesenauer M, Lüdtke R. Mahonia aquifolium in patients with
psoriasis vulgaris—an intraindividual study. Phytomed 1996;3:231–5.
- Galle K, Müller-Jakic B, Proebstle A, et al. Analytical and
pharmacological studies on Mahonia aquifolium. Phytomed
1994;1:59–62.
- Liao, SJ. Acupuncture treatment for psoriasis: a retrospective case report.
Acupunct Electrother Res 1992;17:195–208.
- Jerner B, Skogh M, Vahlquist A. A controlled trial of acupuncture in
psoriasis: no convincing effect. Acta Derm Venereol (Stockh)
1997;77:154–6.
- Kabat-Zinn J, Wheeler E, Light T, et al. Influence of a mindfulness
meditation-based stress reduction intervention on rates of skin clearing in patients with
moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA).
Psychosom Med 1998;60:625–32.
- Shenefelt PD. Hypnosis in dermatology. Arch Dermatol
2000;136:393–9.
- Kline MV. Psoriasis and hypnotherapy: a case report. Int J Clin Exp
Hypn 1954;2:318–22.